Pomalidomide-TL - analogs
Components: Pomalidomide |
|||||||||
Pharmgroups: Immunosuppressants || Other antitumor agents |
|||||||||
Prices in pharmacies: — Instructions Pomalidomide-TL | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Water for injections ✘ (incl) Броксил ✘ (incl) Ambroxol ✘ (incl) ИВ РОШЕ ОМЕГА 3 ВЕЖЕТАЛЬ ✘ (incl) Фиточай «Здоровье и красота» ✘ (incl) Eclaran 10 ✘ (incl) Бетаметазон-ВЕРТЕКС ✘ (incl) Дексаметазон-ЛФ ✘ (incl) Фитол-2 ✘ (incl) Momordica compositum ✘ (incl) Биостим вумен ✘ (incl) Тропикана Слим Гарциния ✘ (incl) Megosinum ✘ (incl) Ginseno Power ✘ (incl) Allertec ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Imnovid neutral | 6352.5-6726.4€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 50% 194.3-777.1€ Darzalex neutral [Daratumumab]
- 47% 788.9€ Kyprolis neutral [Carfilzomib]
- 39% 992.7€ Talcenna neutral [Talazoparib]
- 34% 2417.8€ Ninlaro neutral [Ixazomib]
- 34% 1381.2€ Empliciti neutral [Elotuzumab]
- 34% — Иксазомиба цитрат neutral [Ixazomib]
- 33% 1328€ Revlimid neutral [Lenalidomide]
- 31% — Lenalidomide neutral [Lenalidomide]
- 31% — Ленанжио neutral [Lenalidomide]
- 30% 73.4€ Venclexta neutral [Venetoclax]
- 29% — Майборте neutral [Bortezomib]
- 29% — Бортезомиб Канон neutral [Bortezomib]
- 29% 104.5€ Велмиб3.5 neutral [Bortezomib]
- 29% 296€ Halaven neutral [Eribulin]
- 29% — Милатиб neutral [Bortezomib]
- 28% — Метибластан neutral [Lenalidomide]
- 27% — Сарклиза neutral [Isatuximab]
- 26% — Verozomib neutral [Bortezomib]
- 26% — Тироджин neutral [Thyrotropin alfa]
- 26% 136.3€ Бартизар neutral [Bortezomib]
- 26% 140-149.4€ Velcade neutral [Bortezomib]
- 26% — Bortezol neutral [Bortezomib]
- 26% — БОРАТЕРИН neutral [Bortezomib]
- 25% — Proleukin neutral [Aldesleukin]
- 24% — Фаридак neutral [Panobinostat]
- 24% — Мулмилида neutral [Lenalidomide]
- 24% — Lenalidomide-TL neutral [Lenalidomide]
- 24% — Lenalidomide Canon neutral [Lenalidomide]
- 24% — Миеланикс neutral [Lenalidomide]
- 24% — Леналидомид-Тева neutral [Lenalidomide]
- 24% — Леналидомид (форма-Н1) neutral [Lenalidomide]
- 24% — Lenalidomide-KRKA neutral [Lenalidomide]
- 24% — Леналидомид-промомед neutral [Lenalidomide]
- 24% — РУПСУЛИМИД neutral [Lenalidomide]
- 24% — Ландотекс neutral [Lenalidomide]
- 24% — Lenalidomide-nativ neutral [Lenalidomide]
- 24% — Леноалромид neutral [Lenalidomide]
- 23% 324.5€ Иглиб neutral [Imatinib]
- 23% 798-825€ Ibrance neutral [Palbociclib]
- 23% 807.2-809.8€ Итулси neutral [Palbociclib]
- 23% — Gistamel neutral [Imatinib]
- 23% 15-21€ Цервикон -ДИМ neutral [Diindolylmethane]
- 23% — Nilotinib hydrochloride monohydrate neutral [Nilotinib]
- 23% — Imagliv neutral [Imatinib]
- 23% 220.5-642.6€ Ixempra neutral [Ixabepilone]
- 23% 73.5€ Onicit neutral [Palonosetron]
- 23% — Iimatinib mesilate neutral [Imatinib]
- 23% — Citonib neutral [Imatinib]
- 23% 1296.2-2074.1€ Kadcyla neutral [Trastuzumab emtansine]
- 23% — Imatinib medac neutral [Imatinib]
Learn more about the selection of analogues
- The drug has «Pomalidomide-TL» 3 full analogs, the cheapest - Imnovid (6352.5-6726.4€); 51 analog by action, the most similar - Darzalex (194.3-777.1€).
- Medical online service has selected the best substitutes for Pomalidomide-TL based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Pomalidomide-TL analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.